FDA

Surprising Pandemic-Driven Progress in American Health: Day One Conference Report

Americans are surprisingly optimistic about their health as we collectively emerge from the devastating COVID-19 pandemic, reported John Gerzema, CEO of The Harris Poll, at the outset of the three-day Health+Wealth of America conference Tuesday.

We Need a New International Organization: The Science Readiness Reserves

COVID-19 is a wake-up call for institutional renewal and reform. The only way to face the uncertainties of the future is to build more, stronger public-private partnerships, and on a global basis.

Missing From Clinical Trials: the Patient Perspective

The design and execution of clinical trials represents an ideal opportunity to engage the consumer and begin building a relationship that can last a lifetime.

I Got My Genetic Results. Now What? A Techonomy Guide

Genetic testing has become more mainstream and greater numbers of consumers are receiving their results — and left wondering what they mean and what to do with them. For those who need help navigating and...

FDA Opens the Doors for Consumer Genetic Testing, But is the Technology Ready?

Genetic testing is going mainstream, but is the science ready for prime time? The marketing of genetic tests to consumers raises short-term risks and may even threaten the longer-term promise of the technology.

Seemingly Miraculous New Cancer Gene Therapy Brings Major Risks

A new FDA-approved cancer gene therapy called CAR T recently showed astonishing effectiveness against leukemia in seriously ill patients. Despite their poor prognosis, 83 percent responded to the treatment, and the cancer medical establishment was...

FDA Greenlights 23andMe and Opens New Era for Consumer DNA Info

It was a much-needed breakthrough when the FDA last week OK'd personal genomics company 23andMe selling genetic tests directly to consumers. In 2013 the agency had banned the startup from releasing disease-related information. Now we...

23andMe’s Community Wants to Help, CEO Tells Genomics Researchers

At a genomics conference in February, 23andMe CEO Anne Wojcicki took the stage to make the case for the scientific importance of her consumer genetics platform. Wojcicki still has a grand vision for how the...

Can Hot Consumer Genomics Startup Helix Keep the FDA at Bay?

A new company launched by the market leader in DNA sequencing aims to bring genomics to the masses. Helix, kicked off on August 18 with a capital injection of more than $100 million, appears to...

1 2 3